The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.
Mary Hardcastle at RapidAI looks at the advancements in health tech, explaining what hospitals need to do to implement Artificial Intelligence in the ER.
Olga Gómez de Miranda, Scientific researcher from TECNALIA illustrates the innovative technologies and strategies in place to improve sustainable development.
Cervical cancer is a disease affecting thousands of women in the UK with around 3,200 new cases diagnosed every year, can developments in cervical screening and digital cytology help?
Neil Macdonald, CEO at Thrive, explains how using the Impact Evaluation Standard to report on social value in government contracts can actually lead to far better outcomes for communities and for suppliers.
Dr Helen M Rowe at the Centre for Immunobiology at the Queen Mary University of London looks towards unlocking dark matter for the potential to boost immune responses in humans.
The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.
Y-h. Taguchi, a professor at Chuo University, looks toward a COVID-19 infection model which uses human patients blood who have been infected by COVID-19.
Dayna Arnold, Project Manager at Zest Consult, discusses the benefits of using a synthetic data approach to machine learning as an innovative solution for increasing the availability, accuracy & security of more cost effective data.
